Wael El-Matary
Overview
Explore the profile of Wael El-Matary including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
1397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aziz B, Belaghi R, Huynh H, Jacobson K, Mack D, Deslandres C, et al.
Clin Transl Gastroenterol
. 2025 Jan;
PMID: 39835685
Introduction: Neutrophil-to-lymphocyte ratio (NLR) is a novel biomarker studied in several autoimmune diseases including inflammatory bowel disease (IBD) in adults but poorly characterized in pediatric IBD (pIBD). We aimed to...
2.
Lee S, Bushra M, Qiu L, Shao J, Olivera P, Leibovitzh H, et al.
Gastroenterology
. 2024 Oct;
168(2):385-388.e3.
PMID: 39384162
No abstract available.
3.
Kuenzig M, Walters T, Mack D, Griffiths A, Duchen R, Bernstein C, et al.
Inflamm Bowel Dis
. 2024 Jul;
PMID: 39028498
Background: The incidence of pediatric-onset inflammatory bowel disease (IBD) and the costs of caring for individuals with IBD are both increasing. We calculated the direct healthcare costs of pediatric IBD...
4.
Guz-Mark A, Aloi M, Scarallo L, Bramuzzo M, Escher J, Alvisi P, et al.
Pediatrics
. 2024 Jul;
154(2.
PMID: 39015095
Objectives: This study described disease characteristics and long-term outcomes in patients diagnosed with very early onset inflammatory bowel disease (VEOIBD) (diagnosed before 6 years of age) and infantile-IBD (before 2...
5.
Kennedy A, Griffiths A, Muise A, Walters T, Ricciuto A, Huynh H, et al.
Inflamm Bowel Dis
. 2024 May;
30(12):2418-2427.
PMID: 38788739
Background: Patients with inflammatory bowel disease (IBD) exhibit considerable interindividual variability in medication response, highlighting the need for precision medicine approaches to optimize and tailor treatment. Pharmacogenetics (PGx) offers the...
6.
Xue M, Leibovitzh H, Jingcheng S, Neustaeter A, Dong M, Xu W, et al.
Clin Gastroenterol Hepatol
. 2024 May;
22(9):1889-1897.e12.
PMID: 38759825
Background & Aims: To date, it is unclear how environmental factors influence Crohn's disease (CD) risk and how they interact with biological processes. This study investigates the association between environmental...
7.
8.
Dijk S, Jarman M, Zhang Z, Lawley M, Ahmad M, Suarez R, et al.
Nutrients
. 2024 Apr;
16(7).
PMID: 38613066
Exclusive enteral nutrition (EEN) is effective in inducing remission in pediatric Crohn disease (CD). EEN alters the intestinal microbiome, but precise mechanisms are unknown. We hypothesized that pre-diagnosis diet establishes...
9.
Gerhold K, Al-Azazi S, El-Matary W, Katz L, Lim L, Marks S, et al.
J Pediatr
. 2024 Apr;
271:114046.
PMID: 38582149
Objectives: To understand the burden associated with pediatric chronic pain (CP) on the health care system compared with other costly chronic diseases prior to subspecialty care. Study Design: In this...
10.
Ricciuto A, Liu K, El-Matary W, Amin M, Amir A, Aumar M, et al.
Aliment Pharmacol Ther
. 2024 Mar;
59(10):1236-1247.
PMID: 38462727
Background: Data on oral vancomycin for primary sclerosing cholangitis (PSC)-associated inflammatory bowel disease (IBD) are limited. Aims: Using data from the Paediatric PSC Consortium, to examine the effect of vancomycin...